The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element

AML1 (RUNX1) is a key transcription factor for hematopoiesis that binds to the Runt-binding double-stranded DNA element (RDE) of target genes through its N-terminal Runt domain. Aberrations in the AML1 gene are frequently found in human leukemia. To better understand AML1 and its potential utility for diagnosis and therapy, we obtained RNA aptamers that bind specifically to the AML1 Runt domain. Enzymatic probing and NMR analyses revealed that Apt1-S, which is a truncated variant of one of the aptamers, has a CACG tetraloop and two stem regions separated by an internal loop. All the isolated aptamers were found to contain the conserved sequence motif 5'-NNCCAC-3' and 5'-GCGMGN'N'-3' (M:A or C; N and N' form Watson-Crick base pairs). The motif contains one AC mismatch and one base bulged out. Mutational analysis of Apt1-S showed that three guanines of the motif are important for Runt binding as are the three guanines of RDE, which are directly recognized by three arginine residues of the Runt domain. Mutational analyses of the Runt domain revealed that the amino acid residues used for Apt1-S binding were similar to those used for RDE binding. Furthermore, the aptamer competed with RDE for binding to the Runt domain in vitro. These results demonstrated that the Runt domain of the AML1 protein binds to the motif of the aptamer that mimics DNA. Our findings should provide new insights into RNA function and utility in both basic and applied sciences.

[1]  J. Ebel,et al.  Partial digestion of tRNA--aminoacyl-tRNA synthetase complexes with cobra venom ribonuclease. , 1981, Biochemistry.

[2]  Pierre Plateau,et al.  Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .

[3]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[4]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[5]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Grundström,et al.  Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences , 1991, Journal of virology.

[7]  N. Speck,et al.  Sequence specificity of the core-binding factor , 1993, Journal of virology.

[8]  Gabriele Varani,et al.  NMR investigation of RNA structure , 1996 .

[9]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[10]  J. Bushweller,et al.  Biochemical and Biophysical Properties of the Core-binding Factor α2 (AML1) DNA-binding Domain* , 1996, The Journal of Biological Chemistry.

[11]  S. Yokoyama,et al.  Hairpin structure of an RNA 28-mer, which contains a sequence of the enzyme component of a hammerhead ribozyme system: evidence for tandem G:A pairs that are not of side-by-side type. , 1997, Journal of biochemistry.

[12]  T. Grundström,et al.  Solution properties of the free and DNA-bound Runt domain of AML1. , 1999, European journal of biochemistry.

[13]  B. Chait,et al.  Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain , 2000, Nature Structural Biology.

[14]  D. Patel,et al.  Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics. , 2000, Journal of biotechnology.

[15]  Jerónimo Bravo,et al.  The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp , 2001, Nature Structural Biology.

[16]  T. Tahirov,et al.  Erratum: Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ (Cell 104:5(755-767)) , 2001 .

[17]  Takashi Kumasaka,et al.  Structural Analyses of DNA Recognition by the AML1/Runx-1 Runt Domain and Its Allosteric Control by CBFβ , 2001, Cell.

[18]  U. Sauer,et al.  The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding. , 2002, Journal of molecular biology.

[19]  Takashi Ohtsu,et al.  RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. , 2003, RNA.

[20]  Jeff Zimmerman,et al.  Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Matheny,et al.  Runx1 Is Expressed in Adult Mouse Hematopoietic Stem Cells and Differentiating Myeloid and Lymphoid Cells, But Not in Maturing Erythroid Cells , 2004, Stem cells.

[22]  N. Speck,et al.  Core-binding factors in hematopoiesis and immune function , 2004, Oncogene.

[23]  G. Ghosh,et al.  Molecular mimicry of the NF-κB DNA target site by a selected RNA aptamer , 2004 .

[24]  Takashi Ohtsu,et al.  High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation. , 2005, RNA.

[25]  T. S. Brown,et al.  Method for assigning double-stranded RNA structures. , 2005, BioTechniques.

[26]  Takashi Ohtsu,et al.  RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. , 2006, RNA.

[27]  Yoshikazu Nakamura,et al.  Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. , 2006, Biochimie.

[28]  Yoshikazu Nakamura,et al.  RNA aptamers targeting the carboxyl terminus of KRAS oncoprotein generated by an improved SELEX with isothermal RNA amplification. , 2007, Oligonucleotides.

[29]  B. Johansson,et al.  The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.

[30]  E. Leygue,et al.  Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer , 2007, Nuclear receptor signaling.

[31]  Paulo P. Amaral,et al.  The Eukaryotic Genome as an RNA Machine , 2008, Science.

[32]  A. Hata,et al.  SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.

[33]  Yoshikazu Nakamura,et al.  Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G. , 2008, RNA.

[34]  S. Butcher,et al.  DNA mimicry by a high-affinity anti-NF-κB RNA aptamer , 2007, Nucleic acids research.

[35]  Hiroshi I. Suzuki,et al.  Modulation of microRNA processing by p53 , 2009, Nature.

[36]  J. Mattick.  The Genetic Signatures of Noncoding RNAs , 2009, PLoS genetics.

[37]  D. Littman,et al.  RUNX proteins in transcription factor networks that regulate T-cell lineage choice , 2009, Nature Reviews Immunology.

[38]  Stuart E. Knowling,et al.  Characterization of RNA aptamers that disrupt the RUNX1–CBFβ/DNA complex , 2009, Nucleic Acids Research.

[39]  B. O’Malley,et al.  Maturation of microRNA is hormonally regulated by a nuclear receptor. , 2009, Molecular cell.

[40]  Yoshikazu Nakamura,et al.  A binary Cy3 aptamer probe composed of folded modules. , 2010, Analytical biochemistry.

[41]  G. Chrousos,et al.  Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.

[42]  Trinucleotide repeat system for sequence specificity analysis of RNA structure probing reagents. , 2010, Analytical biochemistry.

[43]  S. Hiebert,et al.  Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia. , 2010, Cancer treatment and research.

[44]  A. Hata,et al.  Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. , 2010, Molecular cell.

[45]  Sonia Sharma,et al.  Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex , 2011, Proceedings of the National Academy of Sciences.

[46]  B. O’Malley,et al.  Retraction notice to: Maturation of microRNA is hormonally regulated by a nuclear receptor. , 2010, Molecular cell.